Filter
420
Filtered Results: 420
Text search:
Roche
Featured
Recommendations
46
New Publications
123
Language
Document type
No document type
250
Guidelines
64
Studies & Reports
60
Manuals
22
Fact sheets
11
Training Material
4
Strategic & Response Plan
3
Resource Platforms
2
Infographics
2
Situation Updates
1
Videos
1
Countries / Regions
Global
20
Kenya
15
Haiti
14
Senegal
11
Nigeria
9
India
9
Germany
8
Bangladesh
8
Brazil
8
Russia
8
Uganda
7
Malawi
7
Zambia
6
Tanzania
6
Western and Central Europe
6
Africa
6
Venezuela
6
Sierra Leone
5
Congo, Democratic Republic of
5
Philippines
5
Colombia
5
Eastern Europe
5
Burkina Faso
4
Liberia
4
Ghana
4
Zimbabwe
4
South Africa
4
Mozambique
4
Ukraine
4
Guinea
3
Mali
3
Ethiopia
3
Cambodia
3
Rwanda
3
Indonesia
3
Peru
3
Guinea-Bissau
2
Nepal
2
Pakistan
2
Jordan
2
Egypt
2
Syria
2
Namibia
2
Bolivia
2
Angola
2
Madagascar
2
Lesotho
2
Chile
2
West and Central Africa
2
Vietnam
2
Jamaica
2
Côte d’Ivoire / Ivory Coast
1
USA
1
Niger
1
Togo
1
South Sudan
1
Thailand
1
Ireland
1
Sudan
1
Benin
1
Central African Republic
1
Dominican Republic
1
North Macedonia
1
Burundi
1
Honduras
1
Ecuador
1
Latin America and the Carribbean
1
Gabon
1
Uruguay
1
France
1
Authors & Publishers
Publication Years
Category
Countries
138
Clinical Guidelines
36
Public Health
21
Women & Child Health
16
Pharmacy & Technologies
13
Key Resources
9
Capacity Building
6
Toolboxes
Mental Health
49
HIV
34
TB
34
COVID-19
34
Zika
28
AMR
15
Pharmacy
14
Ebola
12
Rapid Response
12
NCDs
12
Disability
11
Planetary Health
11
Caregiver
10
NTDs
7
Refugee
6
Natural Hazards
5
Global Health Education
5
Conflict
4
Typhoon
3
Cholera
2
Social Ethics
2
Health Financing Toolbox
1
Global tuberculosis report 2022
recommended
The WHO Global Tuberculosis Report 2022 provides a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease, at global, regional and country levels. This is done in the context of global TB commitments, strategies and targets.
...
Not long ago, on the occasion of the 100th anniversary of the discovery of Chagas disease, several campaigns denounced the scant progress has been made in diffrent spheres- medical, scientific and politcal- but major challanges still remain. This is an appropriate time to celebrate what has been ach...
The Practical manual on laboratory strengthening, 2022 update provides practical guidance on implementation of WHO recommendations and best practices for TB laboratory strengthening. It is an updated version of the GLI Practical Guide to Laboratory Strengthening published in 2017 and provides the la...
To support its R&D activities on Chagas disease, DNDi launched the Chagas Clinical Research Platform (CCRP). The platform brings together partners, experts, and stakeholders to provide support for evaluation and development of new treatments for Chagas disease. The patient-centred platform aims to f...
El desarrollo, desde 1991, de las Iniciativas Subregionales de Control de la Enfermedad de Chagas, y los avances de conocimiento en materia de diagnóstico y manejo de la infección/enfermedad de Chagas, llevan a la necesidad ética, y operativamente imperiosa, de estructurar el diagnóstico, atenci...
Rabies has an enormous impact on both agriculture and conservation biology, but its greatest burden is undeniably on public health. As such, routine methods for rapid risk assessment after human exposures to rabies as well as applications for laboratory-based surveillance, production of biologicals ...
Forests, trees and green spaces, hereinafter ‘forests and trees’ for short, provide multiple goods and services that contribute to human health. These include medicines, nutritious foods and other non-wood forest products (NWFPs). Globally, at least 3.5 billion people use NWFPs, including medici...
This document is an output of a WHO cross-programme initiative aiming to improve the prevention, diagnosis and management of anaemia and thereby accelerate reduction in its prevalence. It comes at an important time, midway through the era of the Sustainable Development Goals, when progress in reduci...
The ninth WHO report on the global tobacco epidemic tracks the progress made by countries in tobacco control since 2008 and, marks 15 years since the introduction of the MPOWER technical package which is designed to help countries implement the demand-reduction measures of the WHO Framework Conventi...
The present information document supplements the WHO audited financial statements for 2018. It contains information on WHO's voluntary contributions by fund and by contributor in the year 2018.
Background: Atherosclerotic cardiovascular diseases (ASCVD) including myocardial infarction, stroke and peripheral arterial disease continue to be major causes of premature death, disability and healthcare expenditure globally. Preventing the accumulation of cholesterol-containing atherogenic lipopr...
ABSTRACT
More than 500 million people worldwide live with cardiovascular disease (CVD). Health systems today face fundamental challenges in delivering optimal care due to ageing populations, healthcare workforce constraints, financing, availability and affordability of CVD medicine, and service del...
The World Heart Federation (WHF) Roadmap series covers a large range of cardiovascular conditions. These Roadmaps identify potential roadblocks and their solutions to improve the prevention, detection and management of cardiovascular diseases and provide a generic global framework available for loca...
Small drinking-water supplies commonly experience operational, managerial, technical and resourcing challenges that impact their ability to deliver safe and reliable services. The needs and opportunities associated with these supplies therefore warrant explicit consideration in policies and regulati...
sthma prevalence is increasing worldwide, and surveys indicate that most patients in developed and developing countries, including South Africa, do not receive optimal care and are therefore not well controlled. Standard management guidelines adapted to in-country realities are important to support ...
Long Acting Muscarinic Antagonists (LAMA) such as tiotropium and glycopyrronium are used in the management of COPD1. They have been shown to improve lung function, quality of life and exercise tolerance. They have also been associated with reduced COPD-related exacerbations, associated hospitalisati...
Research globally has shown that metered dose inhaler (MDI) technique is poor,
with patient education and regular demonstration critical in maintaining correct use of
inhalers. Patient information containing pictorial aids improves understanding of medicine
usage; however, manufacturer leaflets i...
Asthma is the most common chronic condition in children worldwide. It affects daytime activities, sleep and school attendance and causes anxiety to parents, families and other carers. The quality of asthma diagnosis and management globally still needs substantial improvement. From infancy to the tee...
Improve identification, verification, communication and coordination.
